Cargando…
Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase
Poly(ADP-ribosylation) of proteins following DNA damage is well studied and the use of poly(ADP-ribose) polymerase (PARP) inhibitors as therapeutic agents is an exciting prospect for the treatment of many cancers. Poly(ADP-ribose) glycohydrolase (PARG) has endo- and exoglycosidase activities which c...
Autores principales: | Gravells, Polly, Grant, Emma, Smith, Kate M., James, Dominic I., Bryant, Helen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360195/ https://www.ncbi.nlm.nih.gov/pubmed/28254358 http://dx.doi.org/10.1016/j.dnarep.2017.02.010 |
Ejemplares similares
-
Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib
por: Gravells, Polly, et al.
Publicado: (2018) -
Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
por: Harrision, Daniel, et al.
Publicado: (2020) -
Oncogenic activity of poly (ADP-ribose) glycohydrolase
por: Marques, Maud, et al.
Publicado: (2018) -
The Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase
por: Blenn, Christian, et al.
Publicado: (2011) -
An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cells
por: James, Dominic I., et al.
Publicado: (2016)